Navigation Links
Genesis Biopharma's Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
Date:11/17/2011

LOS ANGELES, Nov. 17, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, today announced that Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch at the National Cancer Institute, has joined the Company's Scientific and Medical Advisory Board.  Dr. Rosenberg also is Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences, both in Washington D.C.  

"We are honored to have Dr. Rosenberg serve on our Scientific and Medical Advisory Board.  A leading authority on immunology and cancer, Dr. Rosenberg pioneered adoptive cell therapy using autologous tumor infiltrating lymphocytes (TILs) to successfully treat patients with metastatic melanoma," stated Anthony J. Cataldo, Chairman and Chief Executive Oficer of Genesis Biopharma.  Genesis Biopharma recently licensed rights to certain intellectual property relating to the use of adoptive cell therapy using autologous TILs for the treatment of metastatic melanoma, ovarian, breast and colorectal cancers from the National Institutes of Health.  "As the inventor of this therapy, Dr. Rosenberg will be an invaluable asset to Genesis Biopharma as we advance the clinical development for Contego™, our ready-to-infuse adoptive cell therapy using TILs, to treat Stage IV metastatic melanoma," added Mr. Cataldo.

Dr. Rosenberg has pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. He has also pioneered the development of gene therapy, and was first to successfully insert foreign genes into humans and to conduct clinical studies of the gene therapy of cancer.

Dr. Rosenberg's work in tumor immunology was recently highlighted in the July issue of Oncology Times in an article titled, "'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
2. ThermoGenesis Corp. to Announce First Quarter Fiscal 2012 Results on November 10, 2011
3. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
4. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
5. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
6. ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent
7. ThermoGenesis Presentation at Rodman & Renshaw Conference
8. Genesis Biopharma Announces Letter to Shareholders Posted to Website
9. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
10. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
11. Genesis Biopharma to Hold Business Update Conference Call on June 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HAMILTON, N.J. , Oct. 22, 2014 ... CLIA-certified, CAP-accredited laboratory which specializes in high ... that it is now offering new Cystic ... including next- generation DNA sequencing platforms. ... a genetically inherited multisystem disorder that affects ...
(Date:10/22/2014)... , Oct 22, 2014 Antigen Discovery ... Irvine, California , announced the receipt of a ... Innovation Research award (SBIR) from the National Institute of Dental and ... the development of a Pan-HIV Protein Microarray Chip, which ... and HIV-2 subtypes and aid in the development of ...
(Date:10/22/2014)... AVACEN Medical announced today that its AVACEN ... clearance by the U.S. Food and Drug Administration. This ... the Internet for: the temporary relief of joint ... and sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... is a sophisticated medical device incorporating over 3,000 firmware ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests 2Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2
... International,Inc. (NYSE: BAX ) announced today that ... IX proteins to treat hemophilia B.,Baxter will develop ... of acute bleeding episodes and a chemically modified, ... of bleeding in,hemophilia B patients. Hemophilia B is ...
... Nanoparticles May Deliver Treatments to Human,Organs -, PHILADELPHIA, ... iron-bearing particles to drive healthy cells to,targeted sites in ... to,a new method of delivering cells and genes to ... http://www.newscom.com/cgi-bin/prnh/20080107/DC10966 ), The study team, led by ...
Cached Medicine Technology:Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 3Researchers Use Magnetism to Target Cells to Animal Arteries 2Researchers Use Magnetism to Target Cells to Animal Arteries 3Researchers Use Magnetism to Target Cells to Animal Arteries 4
(Date:10/25/2014)... Minneapolis, Minnesota (PRWEB) October 25, 2014 ... a testing firm which verifies IT-accessibility for disabled ... their Access Approved® logo to Mackin Educational ... digital resource management system and to the ... for the "Own Best Medicine" website. ...
(Date:10/25/2014)... York (PRWEB) October 25, 2014 ... lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against Boston ... in U.S. District Court, Southern District of West ... Judgment on Punitive Damages in a group of ... a ruling issued on October 21st, U.S. District ...
(Date:10/25/2014)... Steven Reinberg HealthDay ... The virus that causes common cold sores -- herpes simplex ... by Swedish researchers suggest. In fact, being a carrier ... of Alzheimer,s disease, the researchers found. "The identification ... dementia disorder is a breakthrough," said lead researcher Dr. Hugo ...
(Date:10/25/2014)... -- Current osteoporosis screening guidelines and tools fail ... for osteoporosis-related fractures, a new study says. ... tools that help us accurately predict who will ... target these at-risk people for preventive measures," study ... the division of general internal medicine and health ...
(Date:10/22/2014)... On Saturday, October 25, 2014, the Brownsville Community Health Center ... fair ¡Vive tu vida! Get Up! Get Moving!®. The event ... health and wellness for people of all ages and all ... public, will be held at Dean Porter Park, 501 E. ... , “¡Vive tu Vida! Get Up! Get Moving!® helps ...
Breaking Medicine News(10 mins):Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... Suite for the Assessment of the Urinary SystemCHICAGO, April ... and MR imaging systems to physician practices, announced today ... that the U.S. Food and Drug Administration (FDA) has ... package for the assessment of urinary anatomy using multi-slice ...
... District Offers 23andMe Personal Genome Service™ at Health Centers to Encourage Preventive ... ... 27, 2009 -- 23andMe , Inc., an industry leader in personal ... district in California, today announced that PPH will be offering the 23andMe ...
... Society of Breast Surgeons Conference Reveals New Diagnostic ... 27 A study from Beth Israel Medical ... cancer was found in 9 percent of patients ... complement mammography, substantially impacting surgical treatment. A total ...
... Investment Trust Inc. (NYSE: CRE ), today ... before the market opens on Monday, May 11, 2009.The Company ... at 11:00 a.m. Eastern Time to discuss the first quarter ... 888-549-7750 or by visiting the Company,s website at ...
... April 27 The Healthcare Group at ... its 2009 Quarterly Analyst Briefing Presentation on the ... held on Wednesday, April 29, 2009 at 3 ... especially those in high acuity areas, are very ...
... OnCore(r) clinical research management system epitomizes the collaborative development process of ... only sports a sleek new user interface but also incorporates over ... ... Madison, Wis. (PRWEB) April 27, 2009 -- The latest version ...
Cached Medicine News:Health News:Neuisys Announces FDA Clearance of UroCARE 2Health News:23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to Their Genetic Information 2Health News:23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to Their Genetic Information 3Health News:23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to Their Genetic Information 4Health News:Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management 2Health News:Frost & Sullivan Discusses Impact of Economic Meltdown on the European High Acuity Monitoring Systems Markets 2Health News:Frost & Sullivan Discusses Impact of Economic Meltdown on the European High Acuity Monitoring Systems Markets 3Health News:OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development 2Health News:OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development 3Health News:OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development 4
... sunwear, inspired by modern American ... with long lasting wearability. The ... include sophistication, elegance and enduring ... modern shapes, classic styling and ...
... mounting technology has redefined rimless collections forever.,The ... at the end of each frame mounting. ... the bushing that mounts within the lens. ... secure fit is created that far exceeds ...
... collection celebrates the 85th anniversary of the ... feel, the unmistakable icons that made GUCCI ... and sunglass collection, dedicated to a multifaceted ... design that is the hallmark of the ...
... Whisper NG Erbium YAG Extended Ablation laser ... true laser peel with outstanding results and no ... a proprietary fluence level with an extra long ... skin. Peeling is spread over 3-5 days, ...
Medicine Products: